Downregulation of miR‑1266‑5P, miR‑185‑5P and miR‑30c‑2 in prostatic cancer tissue and cell lines

Ostadrahimi,Shiva; Fayaz,Shima; Parvizhamidi,Monireh; Abedi‑Valugerdi,Manuchehr; Hassan,Moustapha; Kadivar,Mehdi; Teimoori‑Toolabi,Ladan; Asgari,Mojgan; Shahrokh,Hossein; Abolhasani,Maryam; Mahdian,Reza; Fard‑Esfahani,Pezhman

doi:10.3892/ol.2018.8336

Downregulation of miR‑1266‑5P, miR‑185‑5P and miR‑30c‑2 in prostatic cancer tissue and cell lines

Authors:
- Shiva Ostadrahimi
- Shima Fayaz
- Monireh Parvizhamidi
- Manuchehr Abedi‑Valugerdi
- Moustapha Hassan
- Mehdi Kadivar
- Ladan Teimoori‑Toolabi
- Mojgan Asgari
- Hossein Shahrokh
- Maryam Abolhasani
- Reza Mahdian
- Pezhman Fard‑Esfahani
View Affiliations

Affiliations: Department of Biochemistry, Pasteur Institute of Iran, Tehran 1316943551, Iran, Department of Experimental Cancer Medicine, Karolinska Institutet Huddinge, Stockholm 14157, Sweden, Department of Molecular Medicine, Biotechnology Research Center, Pasteur Institute of Iran, Tehran 1316943551, Iran, Hashemi Nejad Clinical Research Developing Center, Iran University of Medical Science, Tehran 1449614535, Iran
Published online on: March 23, 2018 https://doi.org/10.3892/ol.2018.8336
Pages: 8157-8164

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Over the latest decade, the role of microRNAs (miRNAs/miRs) has received more attention. miRNAs are small non‑coding RNAs that may serve a role as oncogenes or tumor suppressor genes. Certain miRNAs regulate the apoptosis pathway by influencing pro‑ or anti‑apoptotic genes. We hypothesized that increases in the expression of B cell lymphoma 2 (BCL2) and BCL2‑like 1 (BCL2L1) genes, which have been reported in various types of cancer tissues, may be due to the downregulation of certain miRNAs. The present study aimed to identify miRNAs that target BCL2 and BCL2L1 anti‑apoptotic genes in prostate cancer (PCa) clinical tissue samples. Certain candidate miRNAs were selected bioinformatically and their expression in PCa samples was analyzed and compared with that in benign prostatic hyperplasia (BPH) tissue samples. The candidate miRNAs that targeted BCL2 and BCL2L1 genes were searched in online databases (miRWalk, microRNA.org, miRDB and TargetScan). A total of 12 miRNAs that target the 3'‑untranslated region of the aforementioned genes and/or for which downregulation of their expression has previously been reported in cancer tissues. A total of 30 tumor tissue samples from patients with PCa and 30 samples tissues from patients with BPH were obtained and were subjected to reverse transcription‑quantitative polymerase chain reaction for expression analysis of 12 candidate miRNAs, and the BCL2 and BCL2L1 genes. Additionally, expression of 3 finally selected miRNAs and genes was evaluated in prostate cancer PC3 and DU145 cell lines and human umbilical vein endothelial cells. Among 12 miRNA candidates, the expression of miR‑1266, miR‑185 and miR‑30c‑2 was markedly downregulated in PCa tumor tissues and cell lines. Furthermore, downregulation of these miRNAs was associated with upregulation of the BCL2 and BCL2L1 genes. An inverse association between three miRNAs (miR‑1266, miR‑185 and miR‑30c‑2) and two anti‑apoptotic genes (BCL2 and BCL2L1) may be considered for interventional miRNA therapy of PCa.

View Figures

View References

1	Tabayoyong W and Abouassaly R: Prostate cancer screening and the associated controversy. Surg Clin North Am. 95:1023–1039. 2015. View Article : Google Scholar : PubMed/NCBI
2	Giovannucci E: Medical history and etiology of prostate cancer. Epidemiol Rev. 23:159–162. 2001. View Article : Google Scholar : PubMed/NCBI
3	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
4	Verma A, St Onge J, Dhillon K and Chorneyko A: PSA density improves prediction of prostate cancer. Can J Urol. 21:7312–7321. 2014.PubMed/NCBI
5	Harris WP, Mostaghel EA, Nelson PS and Montgomery B: Androgen deprivation therapy: Progress in understanding mechanisms of resistance and optimizing androgen depletion. Nat Clin Pract Urol. 6:76–85. 2009. View Article : Google Scholar : PubMed/NCBI
6	Xu B, Niu X, Zhang X, Tao J, Wu D, Wang Z, Li P, Zhang W, Wu H, Feng N, et al: miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS. Mol Cell Biochem. 350:207–213. 2011. View Article : Google Scholar : PubMed/NCBI
7	Doench JG and Sharp PA: Specificity of microRNA target selection in translational repression. Genes Dev. 18:504–511. 2004. View Article : Google Scholar : PubMed/NCBI
8	Sayed D and Abdellatif M: MicroRNAs in development and disease. Physiol Rev. 91:827–887. 2011. View Article : Google Scholar : PubMed/NCBI
9	Xu T, Zhu Y, Xiong Y, Ge YY, Yun JP and Zhuang SM: MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology. 50:113–121. 2009. View Article : Google Scholar : PubMed/NCBI
10	Fujita Y, Kojima T, Kawakami K, Mizutani K, Kato T, Deguchi T and Ito M: miR-130a activates apoptotic signaling through activation of caspase-8 in taxane-resistant prostate cancer cells. Prostate. 75:1568–1578. 2015. View Article : Google Scholar : PubMed/NCBI
11	Liu XD, Zhang LY, Zhu TC, Zhang RF, Wang SL and Bao Y: Overexpression of miR-34c inhibits high glucose-induced apoptosis in podocytes by targeting Notch signaling pathways. Int J Clin Exp Pathol. 8:4525–4534. 2015.PubMed/NCBI
12	Wang X, Qiu W, Zhang G, Xu S, Gao Q and Yang Z: MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway. Int J Clin Exp Pathol. 8:5017–5025. 2015.PubMed/NCBI
13	Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
14	Zhang J, Zhang T, Ti X, Shi J, Wu C, Ren X and Yin H: Curcumin promotes apoptosis in A549/DDP multidrug-resistant human lung adenocarcinoma cells through an miRNA signaling pathway. Biochem Biophys Res Commun. 399:1–6. 2010. View Article : Google Scholar : PubMed/NCBI
15	Hossini AM and Eberle J: Apoptosis induction by Bcl-2 proteins independent of the BH3 domain. Biochem Pharmacol. 76:1612–1619. 2008. View Article : Google Scholar : PubMed/NCBI
16	Li CY, Chu JY, Yu JK, Huang XQ, Liu XJ, Shi L, Che YC and Xie JY: Regulation of alternative splicing of Bcl-x by IL-6, GM-CSF and TPA. Cell Res. 14:473–479. 2004. View Article : Google Scholar : PubMed/NCBI
17	Li J and Yuan J: Caspases in apoptosis and beyond. Oncogene. 27:6194–6206. 2008. View Article : Google Scholar : PubMed/NCBI
18	Xu C, Lu Y, Pan Z, Chu W, Luo X, Lin H, Xiao J, Shan H, Wang Z and Yang B: The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci. 120:3045–3052. 2007. View Article : Google Scholar : PubMed/NCBI
19	Revil T, Toutant J, Shkreta L, Garneau D, Cloutier P and Chabot B: Protein kinase C-dependent control of Bcl-x alternative splicing. Mol Cell Biol. 27:8431–8441. 2007. View Article : Google Scholar : PubMed/NCBI
20	Boise LH, González-García M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nuñez G and Thompson CB: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:597–608. 1993. View Article : Google Scholar : PubMed/NCBI
21	Jovanovic M and Hengartner MO: miRNAs and apoptosis: RNAs to die for. Oncogene. 25:6176–6187. 2006. View Article : Google Scholar : PubMed/NCBI
22	Organization WH: National cancer control programmes: Policies and managerial guidelines. World Health Organization; 2002
23	Chen L, Lü MH, Zhang D, Hao NB, Fan YH, Wu YY, Wang SM, Xie R, Fang DC, Zhang H, et al: miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase. Cell Death Dis. 5:e10342014. View Article : Google Scholar : PubMed/NCBI
24	Horsham JL, Kalinowski FC, Epis MR, Ganda C, Brown RA and Leedman PJ: Clinical potential of microRNA-7 in cancer. J Clin Med. 4:1668–1687. 2015. View Article : Google Scholar : PubMed/NCBI
25	Li Z and Rana TM: Therapeutic targeting of microRNAs: Current status and future challenges. Nat Rev Drug Discov. 13:622–638. 2014. View Article : Google Scholar : PubMed/NCBI
26	Wang R, Tian S, Wang HB, Chu DP, Cao JL, Xia HF and Ma X: MiR-185 is involved in human breast carcinogenesis by targeting Vegfa. FEBS Lett. 588:4438–4447. 2014. View Article : Google Scholar : PubMed/NCBI
27	Imam JS, Buddavarapu K, Lee-Chang JS, Ganapathy S, Camosy C, Chen Y and Rao MK: MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers. Oncogene. 29:4971–4979. 2010. View Article : Google Scholar : PubMed/NCBI
28	Zhang Q, Yu L, Qin D, Huang R, Jiang X, Zou C, Tang Q, Chen Y, Wang G, Wang X and Gao X: Role of microRNA-30c targeting ADAM19 in colorectal cancer. PLoS One. 10:e01206982015. View Article : Google Scholar : PubMed/NCBI
29	Guo R, Wang Y, Shi WY, Liu B, Hou SQ and Liu L: MicroRNA miR-491-5p targeting both TP53 and Bcl-XL induces cell apoptosis in SW1990 pancreatic cancer cells through mitochondria mediated pathway. Molecules. 17:14733–14747. 2012. View Article : Google Scholar : PubMed/NCBI
30	Zhao A, Zeng Q, Xie X, Zhou J, Yue W, Li Y and Pei X: MicroRNA-125b induces cancer cell apoptosis through suppression of Bcl-2 expression. J Genet Genomics. 39:29–35. 2012. View Article : Google Scholar : PubMed/NCBI
31	Yang TQ, Lu XJ, Wu TF, Ding DD, Zhao ZH, Chen GL, Xie XS, Li B, Wei YX, Guo LC, et al: MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway. Cancer Sci. 105:265–271. 2014. View Article : Google Scholar : PubMed/NCBI
32	Xiong S, Zheng Y, Jiang P, Liu R, Liu X and Chu Y: MicroRNA-7 inhibits the growth of human non-small cell lung cancer A549 cells through targeting BCL-2. Int J Biol Sci. 7:805–814. 2011. View Article : Google Scholar : PubMed/NCBI